Plenary Lecture
Pyothorax-Associated Lymphoma:
Our Experiences of Five Cases
Associate Professor Kazuhiko Natori
Division of Hematology and Oncology Department of
Medicine
Omori Medical center
Toho University School of Medicine
E-mail:
natori@med.toho-u.ac.jp
Abstract:
Among malignant tumors associated with chronic
tuberculous pyothorax, malignant lymphoma is called
pyothorax-associated lymphoma (PAL). Since the first
report by Shiohara, et al. in 1970, there have been many
reports of PAL, with a particularly high incidence in
Japan. Involvement of Epstein Barr virus (EBV) in the
disease is also suspected. Here we investigated five
patients we experienced during the past 17 years from
1986 to 2002 who were diagnosed as having malignant
lymphoma of thoracic origin secondary to pyothorax.
Patients were four males and one female, all of whom had
history of tuberculosis and artificial pneumothorax, and
developed PAL after a median period of 49 years. The
disease type was non-Hodgkin's B cell lymphoma in all
patients. Immunostaining of histopathological specimens
from all patients showed that 4 patients were positive
for EB virus nuclear antigen 2 (EBNA2) and 2 for latent
membrane protein 1 (LMP1). In Japan, artificial
pneumothorax was performed more actively than in the
United States and Europe as a therapeutic procedure for
tuberculosis which was regarded as a national
affliction. Onset of PAL appears to be under a strong
influence of such treatment, and therefore should be
predictable. Thus, those with a history of tuberculosis
or pyothorax should be monitored over a long period of
time.
|